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Photodynamic therapy of tumors (PDT) is a modern 
low-traumatic method which proved to be effective in the 
treatment of a number of oncological conditions [1–3]. 
Main advantages of the PDT are selectivity of tumor tis-
sue damage and low invasiveness of the procedure that 
allows in certain cases to avoid a surgical intervention 
[4–6]. Besides, an actual absence of serious side ef-
fects distinguishes favourably the PDT from conventional 
chemotherapy and radiotherapy of oncological patients.
However, PDT has an important drawback connect-
ed with innate properties of the light radiation — a small 
depth of light penetration into biological tissues that 
limits drastically practical applications of the method. 
One possible way of overcoming the drawback is em-
ployment of photosensitizers which are accumulated 
by tumors in greater quantity making them sensitive 
to the light of even low intensity. The goal may be 
pursued combining principles of PDT and nanotech-
nology when nanoparticles are used as a vector for 
photosensitizer transportation [7, 8].
The objectives of the study were to synthesize a 
conjugate of the most extensively studied photosen-
sitizer hematoporphyrin with gold nanoparticles, and 
to evaluate its photodynamic activity in experiments 
on cultures of transformed cells. It was shown that 
nanosized gold particles has an ability to selectively 
accumulate in tumor tissues [9], thus adding to the 
porphyrins own tumor selectivity. To our knowledge, 
there are no data published on the PDT application of 
porphyrin conjugates with gold nanoparticles.
MATERIALS AND METHODS
Gold nanospheres (also known as gold colloids) 
of 15 nm and 45 nm in diameter were synthesized by 
controlled reduction of an aqueous HAuCl4 solution 
with citrate [10], stabilizing the colloid by polyvinylpyr-
rolidone. The conjugated photosensitizer was obtained 
with addition of hematoporphyrin to polyvinylpyrro-
lidone-nanogold solution in calculated molar ratio.
T-cell lines MT-4 and Jurkat (human T-cell leukemia) 
were obtained from culture bank of R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and Radiobiology 
and were cultured in standard RPMI-1640 medium sup-
plied with 10% fetal bovine serum. For photodynamic 
treatment with photosensitizing nanocomposite under 
investigation, cell suspensions (2 x 106/ml) in Hanks 
balanced salt solution (pH = 7.2) were prepared from 
cultures of the leukemic cell lines in log phase of growth. 
The cells were incubated (37 °C) for 1.5 h in Hanks’ solu-
tion with the photosensitizer in concentrations specified, 
the photosensitezer was washed off, and then the cells 
were irradiated.
For samples irradiation, the diode laser with radia-
tion wavelength of 635 nm (“Photonica Plus”, Cherkasy, 
Ukraine) and dose rate 50 J/cm2 w was used. The irradiated 
cells viability was evaluated by trypan blue dye exclusion 
test.
To investigate the ability of the composite to in-
duce free radicals and reactive oxygen species (ROS) 
formation, two systems were used: the first one, con-
taining solution of liposomes, produced from lecithin 
preparation Lipin® (“Biolek”, Kharkiv, Ukraine), and the 
second one, the suspension of human leukemic cells 
mentioned above. Lipid peroxidation rate in the model 
solution system was assessed by means of the chemi-
luminescence intensity measuring after the coumarin 
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C-334 (“Sigma-Aldrich”, USA) addition as an enhancer 
(10 μl of 0.05% ethanol solution to 2 ml of the lipo-
some suspension, 0.2 mg of phospholipids her 1 mL 
of 20 mM Tris-buffer with 100 mM KCl, pH = 7.4). The 
measurements were made according to the technique 
of the pharmaceutical substances oxidation activity 
investigation in phospholipid liposome suspensions 
[11, 12] under the constant temperature conditions 
(37 °C) throughout all the observation period.
In cell samples, the production of peroxide com-
pounds, which are considered to be the end products of 
ROS interaction with biological substrates, was revealed 
by enhancement of the Luminol chemiluminescence, fol-
lowing the sample injection into the test Luminol solution 
(0.5 ml of the cells suspension in Hanks solution, 106 cells 
per ml to 2 ml of 10 μM Luminol solution in 60 mM car-
bonate buffer, pH = 10.5, with 5 μM cobalt chloride) [13].
The chemiluminescence intensity was recorded by 
means of multiplier photocell-equipped unit with digital 
pulse counter (“ISKRA” Research Institute, Lugansk, 
Ukraine), communicated to PC for datamation.
To assess free radicals production rate, the chemi-
luminescence curves showing photon counts per 1 s 
(I, s–1) were plotted, and the integral parameter of the 
luminescence intensity during 500 s after the sample 
injection (∑IT, T = 500 s) was calculated.
For the statistical analysis the Student’s test was used.
RESULTS AND DISCUSSION
Chemiluminescence tests. Before starting to 
investigate the photodynamic effects of the hematopor-
phyrin-nanogold composite on cultured malignant cells, 
it was reasonable to elucidate if the composite is capable 
of reactive oxygen species production, which are the im-
mediate cause of the biological substrate alteration by 
PDT. There are two types of the photo-oxidative reactions 
that underlie the photodynamic destruction of tumors 
[14]. Type I reactions involve electron or hydrogen atom 
transfer, producing radical forms of the photosensitizer 
or the substrate. These intermediates may react with 
oxygen to form peroxides, superoxide ions and hydroxyl 
radicals, which initiate free radical chain reactions.
Type II mechanism is mediated by the energy 
transfer process with the transformation of the ground 
state oxygen to the exited singlet oxygen (1O2) and 
with the return of the sensitizer to its ground state. The 
in situ generation of singlet oxygen via type II reac-
tions appears to play the central role in photodynamic 
cytotoxicity because of the highly efficient interaction 
of the 1O2 species with different biological molecules.
In our chemiluminescence tests, the photo-oxida-
tive activity of the hematoporphyrin-nanogold com-
posite in the phospholipid model system turned out 
rather high as it is evidenced by free radical oxidation 
records (Fig. 1). The chemiluminescence intensity in 
liposome suspensions containing the composite, was 
greater than with addition of the pure hematoporphyrin 
(luminescence total ∑I500 exceeded the background 
level by 39.0% and 17.6%, respectively, p < 0.05). 
That may be, presumably, explained by the gold 
nanoparticles catalytic activity resulting in the pero-
xide formation with further substrate oxidizing [15, 16]. 
Hence, enhanced cell-membrane phototoxicity can be 
expected with the nanocomposite as compared to the 
original photosensitizer, and the modified ratio in the 
induction of oxidative reactions type I and type II [17].
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Fig. 1. The chemiluminescence kinetics in phospholipid liposomes 
suspension following its irradiation by red laser light (635 nm, 
50 J/cm2): without photosensitizer (Blank), and with hematopor-
phyrin (HP) or the nanocomposite photosensitizer (HP + Au)
The investigations exploiting cell suspensions 
showed similar patterns in nanocomposite photosen-
sitizer effects upon both Jurkat and MT-4 cell lines 
(Fig. 2). The main trends in cellular reactions to the 
nanocomposite vs the original hematoporphyrin pho-
tosensitizer were decreased “dark” free-radical forma-
tion rate (ΣI500 amounted 38.2% vs 56.6% above the 
background level) and increased free- radical formation 
rate as a result of photodynamic effect (ΣI500 amounted 
438.6% vs 119.2% above the background level) (Fig. 3).
Cell experiments. In experiments with transformed 
cell cultures the nanocomposites with gold particles of 
two sizes (15 nm and 45 nm) were used in which the 
ratio hematoporphyrin : nanogold varied: the hema-
toporphyrine content was constant (5 μg/ml) but gold 
concentrations amounted to 5 μg; 2.5 μg; 1.0 μg or 
0.5 μg. The hematoporphyrin in concentration 5 μg/ml 
had no “dark” cytotoxicity but under light irradiation it 
led to the death of 60–70% of cells. The activity of the 
nanocomposites was quite diffe rent. In Table 1 the data 
on the “dark” cytotoxicity and photodynamic activity of 
the 15 nm nanocomposites tested are given.
As it follows from the Table 1, the nanocomposites 
with hematoporphyrin concentration 5 μg/ml (№ 1–4) 
have some “dark” cytotoxicity: after 1.5 h incubation 
the death of 70–90% cells was observed. Hence, in 
further experiments the preparations diluted 10-fold 
were tested (№ 5, 6). The preparations had no “dark” 
cytotoxicity but their photodynamic activity remained 
rather high: cell irradiation induced the death of 77–
88% cells. After the further 5-fold dilution the photo-
dynamic activity still made 68% (№ 7) and only under 
additional twofold dilution it was actually absent (№ 8).
In Table 2 the data obtained with nanocomposites 
of hematoporphyrin and gold particles of 45 nm are 
shown. It is evident that such nanocomposites also 
have some “dark” cytotoxicity (№ 1–4) but lesser 
than the preparations with nanoparticle diameter of 
15 nm. Ten fold dilution of them practically eliminated 
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the “dark” cytotoxicity while their photodynamic activi-
ty was higher than in analogical 15 nm composites 
(№ 5–8). They remained photodynamically active even 
after further 50-fold dilution (№ 9), and only prepara-
tions with 100-fold less concentration (№ 10) revealed 
the low activity. In Fig. 4 the comparative photodynamic 
efficiency of hematoporphyrin nanocomposites with 
gold particles of 15 nm and 45 nm is presented.
Table 1. “Dark” cytotoxicity and photodynamic activity of hematoporphyrin-
gold nanocomposites with particles diameter of 15 nm (dead cells% 
in MT-4 cell line)
# Nanocomposites(HP μg/ml : Au μg/ml) “Dark” cytotoxicity Photodynamic activity
1 5 : 5 90.1 ± 0.5 100.0 ± 0.0
2 5 : 2.5 69.3 ± 2.7 100.0 ± 0.0
3 5 : 1 86.2 ± 4.0 100.0 ± 0.0
4 5 : 0.5 81.9 ± 3.6 94.1 ± 2.8
5 0.5 : 0.1 0.0 ± 0.0 77.5 ± 3.8
6 0.5 : 0. 05 5.2 ± 0.4 88.5 ± 0.4
7 0.1 : 0.01 1.9 ± 0.4 67.5 ± 1.0
8 0.05 : 0.005 0.7 ± 0.01 12.5 ± 1.3
Table 2. “Dark” cytotoxicity and photodynamic activity of hematoporphyrin-gold 
nanocomposites with particles diameter of 45 nm (dead cells% in MT-4 cell line)
# Nanocomposites(HP μg/ml : Au μg/ml) “Dark” cytotoxicity Photodynamic activity
1 5 : 5 41.3 ± 0.9 100.0 ± 0.0
2 5 : 2.5 22.2 ± 1.2 100.0 ± 0.0
3 5 : 1 81.7 ± 4.0 100.0 ± 0.0
4 5 : 0.5 79.5 ± 2.8 100.0 ± 0.0
5 0.5 : 0.5 10.7 ± 0.2 76.9 ± 2.3
6 0.5 : 0.25 10.9 ± 0.2 100.0 ± 0.0
7 0.5 : 0.1 5.9 ± 0.1 100.0 ± 0.0
8 0.5 : 0. 05 3.7 ± 0.4 100.0 ± 0.0
9 0.1 : 0.01 1.1 ± 0.2 69.1 ± 2.3
10 0.05 : 0.005 0.7 ± 0.01 15.4 ± 1.3
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Fig. 2. The chemiluminescence kinetics in Luminol solution 
following the injection of different cell suspensions irradiated by 
red laser light (635 nm, 50 J/cm2): MT-4 without photosensitizer 
(MT-4 Blank), Jurkat without photosensitizer (Jurkat Blank), 
MT-4 with nanocomposite photosensitizer (MT-4 HP + Au), 
Jurkat with nanocomposite photosensitizer (Jurkat HP + Au)
In conclusion, we established that photodynamic 
in vitro activity of synthesized hematoporphyrin-
nanogold composites is much higher than that of the 
original photosensitizer. The better activity of the 
nanocomposites with gold particles of 45 nm vs such 
of 15 nm, which was demonstrated in the experiments, 
can be apparently connected with the fact that bigger 
particles are able to transport more porphyrin mole-
cules into malignant cells. The results obtained warrant 
the necessity of further studies with hematoporphyrin-
gold nanocomposites in vivo on transplanted tumors 
of animals which have to define the real perspectives 
of the nanocomposites application in PDT.
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Fig. 3. The total intensity of the Luminol solution luminescence 
during 500 s following the injection of different Jurkat cell 
suspensions: irradiated by red laser light (635 nm, 50 J/cm2) 
without photosensitizer (Blank), hematoporphyrin-treated with-
out irradiation (HP), nanocomposite-treated without irradiation 
(HP + Au), irradiated by red laser light (635 nm, 50 J/cm2) after 
hematoporphyrin-treating (HP*), irradiated by red laser light 
(635 nm, 50 J/cm2) after nanocomposite-treating (HP + Au*)
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Fig. 4. Photodynamic activity of hematoporphyrin (HP) and its gold 
nanocomposites (HP + Au) (MT-4 cells, irradiation dose of 50 J/cm2)
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